ResearcherHeidelberg UniversityNo recent work listed

Anne Katrin Berger

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2017: 1 paper

Papers 1

High prevalence of incidental and symptomatic venous thromboembolic events in patients with advanced pancreatic cancer under palliative chemotherapy: A retrosp… Co-author DOI 10.1016/j.pan.2017.04.012 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Wilko Weichert · 1 shared paper, 2017 · strength 0.07
- Paper High prevalence of incidental and symptomatic venous thromboembolic events in patients with advanced pancreatic cancer … DOI 10.1016/j.pan.2017.04.012 ↗
Hans Martin Singh · 1 shared paper, 2017 · strength 0.07
- Paper High prevalence of incidental and symptomatic venous thromboembolic events in patients with advanced pancreatic cancer … DOI 10.1016/j.pan.2017.04.012 ↗
Martin Ronald Sprick · 1 shared paper, 2017 · strength 0.07
- Paper High prevalence of incidental and symptomatic venous thromboembolic events in patients with advanced pancreatic cancer … DOI 10.1016/j.pan.2017.04.012 ↗
Alexander Muckenhuber · 1 shared paper, 2017 · strength 0.07
- Paper High prevalence of incidental and symptomatic venous thromboembolic events in patients with advanced pancreatic cancer … DOI 10.1016/j.pan.2017.04.012 ↗
Andreas Trumpp · 1 shared paper, 2017 · strength 0.07
- Paper High prevalence of incidental and symptomatic venous thromboembolic events in patients with advanced pancreatic cancer … DOI 10.1016/j.pan.2017.04.012 ↗
Christoph Springfeld · 1 shared paper, 2017 · strength 0.07
- Paper High prevalence of incidental and symptomatic venous thromboembolic events in patients with advanced pancreatic cancer … DOI 10.1016/j.pan.2017.04.012 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.